NDC 73043-014 – Temozolomide
Temozolomide 140 mg/1 · Capsule · Oral
Product NDC73043-014
Product details
- Brand name
- Temozolomide
- Generic name
- Temozolomide
- Labeler
- Devatis, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA207658
- Marketed since
- April 28, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Temozolomide 140 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 73043-014-05 | 5 CAPSULE in 1 BOTTLE (73043-014-05) | Apr 1, 2025 |
| 73043-014-14 | 14 CAPSULE in 1 BOTTLE (73043-014-14) | Apr 1, 2025 |
Other Temozolomide products
- 16729-048 Temozolomide 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-049 Temozolomide 20 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-050 Temozolomide 100 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-051 Temozolomide 250 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-129 Temozolomide 140 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-130 Temozolomide 180 mg/1 · Capsule · Accord Healthcare Inc.
- 65162-802 Temozolomide 20 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-801 Temozolomide 5 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-806 Temozolomide 250 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-804 Temozolomide 140 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-805 Temozolomide 180 mg/1 · Capsule · Amneal Pharmaceuticals LLC
- 65162-803 Temozolomide 100 mg/1 · Capsule · Amneal Pharmaceuticals LLC